Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Becton, Dickinson and Company (NYSE:BDX ) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Call Participants Robert Justin Marcus - JPMorgan Chase & Co, Research Division Unidentified Analyst Yes.
Becton, Dickinson: A Dividend King Facing Challenges Offers Value
Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent dividend safety, and a conservative payout ratio, making it a reliable Dividend King. Despite tariff headwinds, competition, and restructuring risks, BDX's innovation, acquisitions, and organic growth support long-term revenue and EPS expansion.
BD Stock Might See Short-term Decline After Warning on Tamponade Tubes
BDX warns of safety risks tied to its esophagogastric balloon tamponade tubes after one death and two injuries, prompting updated usage instructions for clinicians.
BD Stock May Rise Following the Launch of FACSDiscover A8 Platform
BDX unveils the BD FACSDiscover A8, a next-gen cell analyzer with spectral flow cytometry and real-time imaging, enabling deeper insights into cell function and biology.
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)
Becton, Dickinson and Company (NYSE:BDX ) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and President Conference Call Participants Travis Steed - Bank of America Securities Travis Steed [Starts Abruptly] I'm Travis Steed, Medical Device Analyst at Bank of America and I'm fortunate to have Tom Polen up next, CEO at Becton, Dickinson. So welcome.
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next
I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. High-yield aristocrats offer a 7% average yield with 11%-12% long-term return potential, providing low-risk income regardless of market or economic conditions.
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales
Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research instrument sales.
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX ) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom Polen - Chairman, Chief Executive Officer and President Chris DelOrefice - Executive Vice President and Chief Financial Officer Mike Garrison - President of the Medical Mike Feld - President of the Life Sciences Rick Byrd - President of the Interventional Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Matt Taylor - Jefferies Travis Steed - Bank of America Patrick Wood - Morgan Stanley David Roman - Goldman Sachs Matt Miksic - Barclays Operator Hello, and welcome to BD's Second Fiscal Quarter 2025 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at (800) 839-2385 for domestic calls and area code +1-402-220-7203 for international calls.
Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cramer's Stop Trading: Becton Dickinson
CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.
Becton Dickinson (BDX) Q2 Earnings Top Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago.
